We are live on ! Find out more
ALXN

Alexion Pharmaceuticals
ALXN

Delisted

ALXN was delisted on the 20th of July, 2021.

Back to rankings

406 hedge funds and large institutions have $17.3B invested in Alexion Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 406 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more call options, than puts

Call options by funds: $149M | Put options by funds: $97.1M

Holders
406
Holders Change
+406
Holders Change %
–
% of All Funds
13.25%
Holding in Top 10
6
Holding in Top 10 Change
+6
Holding in Top 10 Change %
% of All Funds
0.2%
New
406
Increased
–
Reduced
–
Closed
–
Calls
$149M
Puts
$97.1M
Net Calls
+$51.9M
Net Calls Change
+$51.9M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
US Bancorp
176
US Bancorp
Minnesota
$4.29M +$4.49M +46,544 New
OTPPB
177
Ontario Teachers' Pension Plan Board
Ontario, Canada
$4.26M +$4.45M +46,155 New
Royal London Asset Management
178
Royal London Asset Management
United Kingdom
$4.17M +$4.28M +44,440 New
CCM
179
Cadence Capital Management
Massachusetts
$4.04M +$4.22M +43,810 New
IG
180
ING Group
Netherlands
$4.01M +$4.19M +43,434 New
CPIM
181
Columbia Partners Investment Management
Virginia
$4M +$4.18M +43,409 New
BFIC
182
Bedell Frazier Investment Counselling
California
$3.95M +$3.48M +36,130 New
Mitsubishi UFJ Asset Management
183
Mitsubishi UFJ Asset Management
Japan
$3.94M +$4.11M +42,700 New
BT
184
Beacon Trust
New Jersey
$3.91M +$4.09M +42,423 New
MCM
185
McKinley Capital Management
Alaska
$3.85M +$4.02M +41,741 New
TAM
186
Tocqueville Asset Management
New York
$3.69M +$3.85M +39,990 New
COPPSERS
187
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$3.67M +$3.83M +39,736 New
ROTUOC
188
Regents of the University of California
California
$3.64M +$3.81M +39,485 New
NLGIA
189
Nippon Life Global Investors Americas
New York
$3.59M +$3.75M +38,890 New
Capital Fund Management (CFM)
190
Capital Fund Management (CFM)
France
$3.58M +$3.74M +38,794 New
ZDA
191
Zweig-DiMenna Associates
New York
$3.57M +$3.73M +38,750 New
RG
192
Redmile Group
California
$3.57M +$3.73M +38,700 New
BRA
193
Bender Robert & Associates
California
$3.54M +$3.7M +38,348 New
WAM
194
World Asset Management
Michigan
$3.52M +$3.68M +38,192 New
GACM
195
Green Arrow Capital Management
New York
$3.5M +$3.66M +38,000 New
Nomura Holdings
196
Nomura Holdings
Japan
$3.43M +$3.6M +37,315 New
LBG
197
Lloyds Banking Group
United Kingdom
$3.41M +$3.57M +37,011 New
QI
198
QS Investors
New York
$3.4M +$3.54M +36,700 New
HI
199
HBK Investments
Texas
$3.35M +$3.5M +36,282 New
DILH
200
Dai-ichi Life Holdings
Japan
$3.28M +$3.43M +35,567 New
6 7
8
9 10

ALXN Hedge Fund Activity: Q2 2013 in Review

406 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Alexion Pharmaceuticals (ALXN) for Q2 2013, worth a combined $17.3B.

Buyers outnumbered sellers: 406 funds opened new ALXN positions and 0 closed out — a net gain of 406 holders — while 0 added to existing stakes and 0 trimmed.

  • 406 institutional investors held Alexion Pharmaceuticals (ALXN) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $17.3B of Alexion Pharmaceuticals stock for Q2 2013.
  • 406 funds opened new Alexion Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +406 holders.

Based on aggregated 13F filings for Q2 2013.